Skip to content
ARS Pharmaceuticals Inc icon

ARS Pharmaceuticals Inc

SPRYStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$4.43

Today

+3.0%

YTD

-62.9%

About

ARS Pharmaceuticals Inc is a biotechnology company that develops innovative treatments for autoimmune diseases and severe allergic reactions. It operates primarily in North America, focusing on the development and commercialisation of inhalation products for severe respiratory conditions and major health issues. ARS Pharmaceuticals operates in the biopharmaceutical sector. The company's products are designed to be safe and effective, needle-free and easy for patients and caregivers to administer. Keep up to date on the latest share price changes by adding SPRY stock to your eToro watchlist.

Price chart
Closing price history for SPRY (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-3.97
P/S (TTM)7.96
P/B (TTM)12.86
Market cap$788.47M
Cap tierSmall-cap
Industry avg P/E-43.26

Profitability

Gross margin74.12%
EBIT margin-204.49%
Net margin-267.26%
ROE-136.40%
ROA-64.39%

Earnings & Revenue

Revenue (TTM)$98.99M
Revenue growth (1Y)+1.9%
EPS (TTM)-$2.00
Free cash flow$-175.32M
Total debt$96.52M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.29
Employees163
Next earnings10 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

ARS Pharmaceuticals Inc (SPRY) | Dirk Kuyken